ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 33530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 33530; 2) Community: the network communities that were significantly associated with the response to NSC 33530; 3) Molecule: the relationships between components within communities and NSC 33530; 4) MDR: the compounds that were significantly associated with the NSC 33530.

NSC Compound Enrichment Correlation
NSC 668496 Null 0.0176693828663438 0.22996677
NSC 677666 Null 0.0176693828663438 0.051610829
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.0176693828663438 0.089527439
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.0176693828663438 0.026791944
NSC 751902 2-4-[5-(3,4-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,7-dimethoxy-1,3-benzothiazole 0.0176693828663438 0.11138712
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0181211508101517 0.48058167
NSC 627992 Null 0.0181211508101517 0.07351496
NSC 629736 Null 0.0181211508101517 0.031638524
NSC 639734 Null 0.0181211508101517 0.27943436
NSC 641054 Null 0.0181211508101517 0.53202804
Total:99  Current:36    [First] [Prev] [Next] [Last]